Company / Revenue
PULSE BIOSCIENCES, INC. Revenue History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$350.0K
FY2025
5-year range
$0 / $1.4M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#156 of 156
Health Care
What the data says
Among 156 Health Care companies, PULSE BIOSCIENCES, INC. is in the bottom 0% for revenue. Declined from $700,000 to $350,000 over the past 2 years.
Based on SEC 10-K filings.
$350,000 in FY2025 with a 3-year CAGR of -20.6%.
Declined from $700,000 to $350,000 over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -20.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 156This company $350.0K Sector average $19.0B
▼
-100.0% below sector average
Key checks
Key Insights
- 3-year CAGR of -20.6%, indicating a declining trend.
- Ranks #156 out of 156 companies in the Health Care sector.
- Peak revenue was recorded in FY2021.
- Lowest revenue in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $350.0K | - |
| FY2024 | $0 | -100.0% |
| FY2023 | $700.0K | +0.0% |
| FY2022 | $700.0K | -50.6% |
| FY2021 | $1.4M | - |
| FY2020 | $0 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026